Dataset of COVID-19 diagnostic tests that have been developed around the world

Diagnostic test is the safety
barrier that helps contain the spread of an infectious disease. Thus, it is
without doubt that the world turned to diagnostic companies for help in
detecting and containing the spread of SARS-CoV-2 in this pandemic. Different
diagnostic tests that range from RT-PCR, antigen rapid tests, and antibody
tests have been developed. This dataset is a collection of clinical diagnostic
tests that have been developed by companies and research labs around the world.
Analysis of this dataset reveals that United States still leads the world in
clinical diagnostics for SARS-CoV-2 detection, with China, Singapore, South
Korea, Germany, United Kingdom, and France also having developed significant
number of diagnostic tests in aid of detection of the virus. Embedded in the
data is the observation that technologically advanced economies with
significant outlay in research and development such as Singapore and South
Korea are starting to emerge as important players in clinical diagnostics with
a range of tests developed. Results such as these also shows that clinical
diagnostics may be one area of research and development where it is more likely
to reap the benefits of the initial investment given the availability of a
capable research workforce and research governance structure. Overall, the
dataset should be a useful resource for understanding the prevailing trends in
clinical diagnostic development on SARS-CoV-2 detection around the world.